TD Asset Management Inc Reduces Position in HCA Healthcare, Inc. $HCA

Key Points

• TD Asset Management Inc reduced its holdings in HCA Healthcare by 13.9% during the second quarter, owning 577,618 shares worth approximately $221 million after selling 92,951 shares.
• HCA Healthcare reported $6.84 EPS for the recent quarter, exceeding analysts’ estimates of $6.20, and had a revenue of $18.61 billion, marking a 6.4% increase year-over-year.
• HCA Healthcare announced a quarterly dividend of $0.72, representing an annualized yield of 0.7%, with a payout ratio of 12.11%.

TD Asset Management Inc lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 13.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 577,618 shares of the company's stock after selling 92,951 shares during the period. TD Asset Management Inc owned 0.24% of HCA Healthcare worth $221,285,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of HCA. Cheviot Value Management LLC acquired a new position in HCA Healthcare in the 1st quarter valued at about $26,000. Saudi Central Bank acquired a new position in HCA Healthcare in the 1st quarter valued at about $26,000. WPG Advisers LLC acquired a new position in HCA Healthcare in the 1st quarter valued at about $27,000. Ameriflex Group Inc. acquired a new position in HCA Healthcare in the 2nd quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at about $27,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Down 1.1%

Shares of NYSE:HCA opened at $410.71 on Tuesday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $439.01. The company's 50 day moving average is $406.07 and its two-hundred day moving average is $376.56. The company has a market cap of $96.10 billion, a PE ratio of 17.26, a P/E/G ratio of 1.31 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the prior year, the firm posted $5.50 EPS. The company's quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on HCA. Robert W. Baird upped their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. UBS Group set a $465.00 price objective on shares of HCA Healthcare in a report on Wednesday, October 8th. The Goldman Sachs Group set a $470.00 price objective on shares of HCA Healthcare in a report on Tuesday. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Finally, Weiss Ratings reaffirmed a "buy (b-)" rating on shares of HCA Healthcare in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $425.71.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.30% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.